RBSH (Rebus Hldgs) Current Accrued Expense: $0.79 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rebus Hldgs Current Accrued Expense?

Rebus Hldgs RBSH -99.00% Current Accrued Expense is $0.79 Mil as of Jun. 2023.

Rebus Hldgs's Current Accrued Expense for the quarter that ended in Jun. 2023 was $0.79 Mil.

Rebus Hldgs's quarterly Current Accrued Expense increased from Dec. 2022 ($0.75 Mil) to Mar. 2023 ($0.77 Mil) and increased from Mar. 2023 ($0.77 Mil) to Jun. 2023 ($0.79 Mil).

Rebus Hldgs's annual Current Accrued Expense increased from Dec. 2020 ($0.61 Mil) to Dec. 2021 ($0.68 Mil) and increased from Dec. 2021 ($0.68 Mil) to Dec. 2022 ($0.75 Mil).

Rebus Hldgs Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Rebus Hldgs's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rebus Hldgs Current Accrued Expense Chart

Rebus Hldgs Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.49 0.54 0.61 0.68 0.75

Rebus Hldgs Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.75 0.75 0.77 0.79

Rebus Hldgs Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.79 Mil mean?
Rebus Hldgs (RBSH) has a Current Accrued Expense of $0.79 Mil as of Jun. 2023. Current Accrued Expense records the total amount of accrued expenses. View historical data on Rebus Hldgs and its competitors.
Is Rebus Hldgs' Current Accrued Expense too high?
Rebus Hldgs' current Current Accrued Expense is $0.79 Mil.
How does Rebus Hldgs' Current Accrued Expense compare to KRBP and CNBX?
Rebus Hldgs' Current Accrued Expense of $0.79 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Biotechnology company?
A good Current Accrued Expense depends on the Biotechnology industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Rebus Hldgs and its competitors. Rebus Hldgs's current Current Accrued Expense is $0.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rebus Hldgs stock overvalued right now?
Rebus Hldgs (RBSH) has a current Current Accrued Expense of $0.79 Mil. The current Current Accrued Expense is $0.79 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Rebus Hldgs (RBSH), the current Current Accrued Expense is $0.79 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rebus Hldgs Business Description

Address 2629 Townsgate Road, Suite 215, Westlake Village, CA, USA, 91361
Rebus Hldgs Inc is an early-stage, pre-revenue, pharmaceutical company that is focused on the development of prodrug cancer therapeutics for the treatment of disease. The company along with its subsidiaries is engaged in the production of small-molecule adenosine receptor modulators. Adenosine is an extracellular signaling molecule that regulates multiple aspects of tissue function and specifically plays a role in immunity and inflammation.